Detalles de la búsqueda
1.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons agedâ¯≥â¯65â¯years: results from a VEBIS network, Europe, October 2021 to July 2023.
Euro Surveill
; 29(1)2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179626
2.
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.
Euro Surveill
; 29(15)2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38606570
3.
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
Euro Surveill
; 28(26)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382885
4.
Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021.
Emerg Infect Dis
; 28(8): 1699-1702, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35732195
5.
Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study.
BMC Public Health
; 21(1): 192, 2021 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33482767
6.
Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020.
Euro Surveill
; 25(26)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32643601
7.
Incidence estimation from sentinel surveillance data; a simulation study and application to data from the Belgian laboratory sentinel surveillance.
BMC Public Health
; 19(1): 982, 2019 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31337363
8.
Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium.
Vaccine X
; 18: 100496, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38779406
9.
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Influenza Other Respir Viruses
; 18(4): e13292, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654485
10.
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium.
Vaccines (Basel)
; 11(2)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851257
11.
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.
Vaccine
; 41(20): 3292-3300, 2023 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085456
12.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Influenza Other Respir Viruses
; 17(11): e13195, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019704
13.
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
Viruses
; 14(4)2022 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35458532
14.
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Vaccine
; 40(22): 3027-3037, 2022 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35459558
15.
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.
Viruses
; 14(6)2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746768
16.
COVID-19 contact tracing in Belgium: main indicators and performance, January - September 2021.
Arch Public Health
; 80(1): 118, 2022 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35418097
17.
Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study.
Lancet Infect Dis
; 21(1): 127-136, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702303
18.
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
Vaccine
; 39(39): 5456-5460, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34454789
19.
All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century.
Arch Public Health
; 78(1): 117, 2020 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292536
20.
Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
Vaccine
; 38(16): 3243-3254, 2020 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171573